Roivant Sciences Ltd. (ROIV) on GreekSoup https://greeksoup.ai/stocks/us/roiv/ Every dated entry in the public record on Roivant Sciences Ltd.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Fri, 09 Oct 2026 00:00:00 +0000 Roivant Sciences Ltd.: Epperly Melissa B, (Director) sold 16,850 shares at $36.08 on 1 October 2026, $607,948https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-10-05:ea6747a014Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Epperly Melissa B, (Director) sold 900 shares at $36.57 on 1 October 2026, $32,913https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-10-05:7a40589bd7Mon, 05 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Venker Eric (President & Immunovant CEO) sold 200,000 shares at $36.62 on 30 September 2026, $7.3 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-10-02:25804030f1Fri, 02 Oct 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, Venker Eric plans to sell 200,000 shares worth $7.3 million around 30 September 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-09-30:a7cb962326Wed, 30 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed 8-K: shareholder votehttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-09-18:fa9d42d92fFri, 18 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Epperly Melissa B, (Director) sold 4,338 shares at $39.65 on 15 September 2026, $172,002https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-17:b4fa2721dcThu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Epperly Melissa B, (Director) sold 600 shares at $40.38 on 15 September 2026, $24,228https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-17:ceb82d3569Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Fitzgerald Meghan (Director) sold 4,712 shares at $39.68 on 15 September 2026, $186,972https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-17:275587f582Thu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Fitzgerald Meghan (Director) sold 400 shares at $40.45 on 15 September 2026, $16,180https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-17:cc37b1f47fThu, 17 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MEGHAN FITZGERALD plans to sell 5,112 shares worth $209,694 around 15 September 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-09-15:675ae410a6Tue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MELISSA EPPERLY plans to sell 22,688 shares worth $930,662 around 15 September 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-09-15:8e27e04a7bTue, 15 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: short interest 36,181,548 shares at the 15 September 2026 settlement, 4.13 days to coverhttps://greeksoup.ai/stocks/us/roiv/short-interest/us:ROIV:short-interest:2026-09-15:7d920e7966Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Fitzgerald Meghan (Director) sold 20,000 shares at $39.90 on 8 September 2026, $798,000https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-10:03b4155a45Thu, 10 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-09-08:f9c408effcTue, 08 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MEGHAN FITZGERALD plans to sell 20,000 shares worth $698,600 around 8 September 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-09-08:8467194ee6Tue, 08 Sep 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Venker Eric (President & Immunovant CEO) sold 166,182 shares at $35.63 on 28 August 2026, $5.9 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-01:642aebd068Tue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Venker Eric (President & Immunovant CEO) sold 33,818 shares at $36.44 on 28 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-09-01:ecd1bbe8ffTue, 01 Sep 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: short interest 33,522,300 shares at the 31 August 2026 settlement, 3.83 days to coverhttps://greeksoup.ai/stocks/us/roiv/short-interest/us:ROIV:short-interest:2026-08-31:0a71419ac7Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed 8-K: other eventshttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-08-28:5f12383c75Fri, 28 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, Venker Eric plans to sell 200,000 shares worth $7.1 million around 28 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-28:cdb932a32aFri, 28 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed 8-K: regulation fd disclosurehttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-08-27:9af9c10cf5Thu, 27 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MAYUKH SUKHATME plans to sell 144,756 shares worth $5.3 million around 21 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-21:8f5d130787Fri, 21 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 144,756 shares at $36.48 on 21 August 2026, $5.3 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-21:2be6485a49Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 17,519 shares at $37.30 on 20 August 2026, $653,459https://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-21:a084fd6d85Fri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 172,899 shares at $37.17 on 19 August 2026, $6.4 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-21:7e1a50233dFri, 21 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MAYUKH SUKHATME plans to sell 17,519 shares worth $653,408 around 20 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-20:068dd5d593Thu, 20 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MAYUKH SUKHATME plans to sell 172,899 shares worth $6.4 million around 19 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-19:f6883b2b70Wed, 19 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MAYUKH SUKHATME plans to sell 136,942 shares worth $5.0 million around 18 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-18:fa859777feTue, 18 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 105,141 shares at $36.59 on 18 August 2026, $3.8 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-18:76b24df9e3Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 31,801 shares at $37.18 on 18 August 2026, $1.2 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-18:4bbec512a1Tue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 284,707 shares at $36.25 on 17 August 2026, $10.3 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-18:c7535a138bTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Sukhatme Mayukh (President & CIO) sold 243,177 shares at $36.23 on 14 August 2026, $8.8 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-08-18:bc43a5e22fTue, 18 Aug 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MAYUKH SUKHATME plans to sell 284,707 shares worth $10.3 million around 17 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-17:13949453edMon, 17 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, MAYUKH SUKHATME plans to sell 243,177 shares worth $8.8 million around 14 August 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-08-14:e6718035deFri, 14 Aug 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: short interest 30,601,726 shares at the 14 August 2026 settlement, 5.01 days to coverhttps://greeksoup.ai/stocks/us/roiv/short-interest/us:ROIV:short-interest:2026-08-14:f8654b43e4Fri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Schedule 13G/A filed by Morgan Stanley, 5.7% of the classhttps://greeksoup.ai/stocks/us/roiv/holders/us:ROIV:schedule-13:2026-08-13:f205629ac1Thu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. Q1 FY2026 results: revenue $1 million, net income -$190 millionhttps://greeksoup.ai/stocks/us/roiv/results/fy2026-q1/us:ROIV:result:2026-08-06:4aacad0227Thu, 06 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-08-06:c611b8346bThu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-08-06:d646675946Thu, 06 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: short interest 35,233,818 shares at the 31 July 2026 settlement, 7.99 days to coverhttps://greeksoup.ai/stocks/us/roiv/short-interest/us:ROIV:short-interest:2026-07-31:ece7fd3b81Fri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed ARS: arshttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-07-29:c067ada502Wed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed DEFA14A: defa14ahttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-07-29:975035eb88Wed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd. filed DEF 14A: def 14ahttps://greeksoup.ai/stocks/us/roiv/filings/us:ROIV:filing:2026-07-29:23a0665948Wed, 29 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Venker Eric (President & Immunovant CEO) sold 200,000 shares at $34.95 on 27 July 2026, $7.0 millionhttps://greeksoup.ai/stocks/us/roiv/insiders/us:ROIV:insider:2026-07-29:faabdbc735Wed, 29 Jul 2026 00:00:00 +0000Insider tradeInsider trade. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: Form 144, Venker Eric plans to sell 200,000 shares worth $7.0 million around 27 July 2026https://greeksoup.ai/stocks/us/roiv/planned-sales/us:ROIV:planned-sale:2026-07-27:276e45d24cMon, 27 Jul 2026 00:00:00 +0000Form 144Form 144. The filing. The page on GreekSoup.

]]> Roivant Sciences Ltd.: short interest 36,695,558 shares at the 15 July 2026 settlement, 7.65 days to coverhttps://greeksoup.ai/stocks/us/roiv/short-interest/us:ROIV:short-interest:2026-07-15:a6e973c5b1Wed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>